Drug
Icp 192
Icp 192: highest development phase Phase 2, developed by InnoCare Pharma. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- InnoCare Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| ICP-192 NCT04492293 | Phase 2 | Bladder Urothelial Cancer |
| ICP-192 NCT03758664 | Phase 1/2 | Solid Tumor |
Latest
No recent events.
Follow Icp 192 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.